Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
iCELL-SCI
- Development stage
- Preclinical
- Lead developer
- iCELL Biotechnology
- Modality
- Stem Cell Therapies → Cell Therapies
01
Overview
iCELL-SCI is an investigational cell therapy developed by iCELL Biotechnology for the treatment of spinal cord injury (SCI). The therapy utilizes Human Amniotic Epithelial Stem Cells (hAESCs), which are harvested from the amniotic membrane of the human placenta. These cells possess stem cell-like properties, including the ability to differentiate into multiple cell lineages and secrete various neurotrophic factors. hAESCs are characterized by low immunogenicity and significant immunomodulatory properties, making them suitable for allogeneic transplantation without the need for intensive immunosuppression. In the context of spinal cord injury, iCELL-SCI aims to promote neural repair, axonal regeneration, and functional recovery by modulating the local inflammatory microenvironment and providing neuroprotection. The program is currently in the preclinical stage of development.
- Other names
- Human Amniotic Epithelial Stem CellshAESC
Beyond the preview
Go deeper on iCELL-SCI.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on iCELL-SCI.